While the AMPK–PGC‐1α signaling may help counteract skeletal muscle atrophy, AMPK–mTOR inhibition or AMPK–ubiquitin proteasomal system may accelerate sarcopenia. This evidence concerns the gene PRKAA1 and sarcopenia.